Related Experiment Video
Updated: Apr 13, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
5.0K
Practical recommendations for the management of hyperlipidemia
S Fischer1, U Schatz1, U Julius1
1Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.
Atherosclerosis. Supplements
|May 5, 2015
Summary
Hyperlipidemia management involves lifestyle changes and medications like statins. Genetic analysis may predict statin side effects, and drug combinations benefit patients with kidney issues.
Area of Science:
- Cardiology
- Metabolic Disorders
- Pharmacogenomics
Background:
- Hyperlipidemia, characterized by elevated cholesterol and triglycerides, is a significant risk factor for atherosclerosis.
- Raised low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) are severe risk factors, while the role of high-density lipoprotein cholesterol (HDL-C) remains debated.
- Accurate lipid level assessment requires fasting blood samples.
Purpose of the Study:
- To review current understanding and management strategies for hyperlipidemia.
- To discuss the efficacy and side effects of various lipid-lowering therapies.
- To highlight advancements in personalized medicine for hyperlipidemia treatment.
Main Methods:
- Review of epidemiological data and clinical trial findings on hyperlipidemia.
- Analysis of pharmacological interventions, including statins, ezetimibe, and others.
- Exploration of genetic factors influencing statin response and management in specific populations.
Main Results:
- Lifestyle modifications (diet, exercise, weight reduction) are foundational. Statins are first-line drugs, with ezetimibe, bile acid sequestrants, fibrates, and fish oil as alternatives.
- Statin use is associated with myopathies and an increased risk of diabetes mellitus.
- Genetic analysis shows promise in predicting individual statin tolerance and efficacy, particularly for simvastatin.
- The combination of simvastatin and ezetimibe demonstrated cardiovascular event reduction in patients with renal insufficiency (SHARP Study).
Conclusions:
- Effective hyperlipidemia management requires a multi-faceted approach including lifestyle changes and pharmacotherapy.
- Personalized treatment strategies, informed by genetic data, can mitigate statin-related side effects.
- Combination therapy is beneficial for high-risk patients, including those with renal insufficiency.
- Primary prevention of hyperlipidemia in young patients presents ongoing challenges.
Related Concept Videos
01:26Atherosclerosis III: Management
603
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
603
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
901
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
901
01:26Coronary Artery Disease IV: Preventive Measures
866
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
01:18Lipids: Dietary Sources and Requirements
2.7K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.7K
01:26Angina IV: Management
441
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
441